GlaxoSmithKline PLC Director/PDMR Shareholding (8795R)
01 July 2015 - 10:56PM
UK Regulatory
TIDMGSK
RNS Number : 8795R
GlaxoSmithKline PLC
01 July 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
I give below details of changes in the Directors' interests in
the Ordinary Shares and American Depositary Shares ('ADSs') of
GlaxoSmithKline plc ('Company').
On 30 June 2015, the Company's Non-Executive Directors were
allocated notional Ordinary Shares at a price of GBP13.45 per
Ordinary Share, and notional ADSs at a price of $42.20 per ADS
under the share allocation arrangements for Non-Executive Directors
for the period of service from 1 April 2015 to 30 June 2015:
Non Executive Ordinary
Director Shares No. of ADSs
Sir Philip Hampton 2,730.912
Professor Sir
Roy Anderson 673.792
Dr Stephanie Burns 539.199
Stacey Cartwright 534.387
Lynn Elsenhans 1,070.720
Judy Lewent 457.147
Sir Deryck Maughan 1,359.719
Dr Daniel Podolsky 1,019.789
Urs Rohner 589.536
Hans Wijers 534.387
The Company and the Non-Executive Directors were informed of
these allocations on 1 July 2015.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 July 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLFLFBEDFEBBL
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024